We are sharing information about a study to evaluate patient preferences for treatment goals in inflammatory bowel disease (IBD). The primary objective of this study is to evaluate and quantify patient preferences for IBD treatments, trading-off between different attributes of efficacy, complications/risks of treatment and health-related quality of life (HRQOL) in IBD. This will be a multi-country, cross-sectional, non-interventional online survey in adult patients with IBD. The study is available in English, French, German, Dutch, Italian, Portuguese and Spanish.
The study is being sponsored by AbbVie.
Please follow the link to go to the study; https://de1.surveyengine.com/47h7h837nkakv66t8fur3qhljoush5vq1s2l1hk3h85ls07mh7c09ni743bcfdqgsk